Evidence map›Paper›PMID 35021092›Full record

ArticleCell reports2022

CDC42 controlled apical-basal polarity regulates intestinal stem cell to transit amplifying cell fate transition via YAP-EGF-mTOR signaling.

Zheng Zhang, Feng Zhang, Ashley Kuenzi Davis, Mei Xin, Gerd Walz, Weidong Tian, Yi Zheng

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Advanced Macromolecular Architectures via Inorganic Polymers.Macromolecular rapid communications · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. CDC42 Regulatory Patterns Related To Inflammatory Bowel Disease and Hyperglycemia.Journal of bioinformatics and systems biology : Open access · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Zheng ZhangDivision of Experimental Hematology and Cancer Biology, Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA.
Feng ZhangDivision of Experimental Hematology and Cancer Biology, Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA.
Ashley Kuenzi DavisDivision of Experimental Hematology and Cancer Biology, Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA.
Mei XinDivision of Experimental Hematology and Cancer Biology, Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA.
Gerd WalzDepartment of Medicine IV, University Freiburg Medical Center, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106 Freiburg, Germany; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Albertstrasse 19, 79104 Freiburg, Germany.
Weidong TianDivision of Experimental Hematology and Cancer Biology, Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA.
Yi ZhengDivision of Experimental Hematology and Cancer Biology, Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA. Electronic address: yi.zheng@cchmc.org.
Cincinnati Children's Hospital Medical Center · USUniversity of Freiburg · DE

Funding

Stem Cell/Organoid and Genome Editing CoreP30DK078392 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Alexander Miethke · 2007 to 2026
$24.4M
Novel mechanism of intestinal stem cell agingR01AG063967 · NIA · CINCINNATI CHILDRENS HOSP MED CTR · PI ZHENG, YI · 2020 to 2024
$2.5M
Leukemia stem cell polarity and differentiation therapyR01CA204895 · NCI · CINCINNATI CHILDRENS HOSP MED CTR · PI MULLOY, JAMES C, ZHENG, YI · 2017 to 2021
$2.2M
Hippo Signaling in Heart Development and RepairR01HL132211 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI XIN, MEI · 2016 to 2020
$1.9M
NCI NIH HHS R01 CA204895NHLBI NIH HHS R01 HL132211NIA NIH HHS R01 AG063967NIDDK NIH HHS P30 DK078392
6 · The paper itself

Abstract

Epithelial polarity is controlled by a polarity machinery that includes Rho GTPase CDC42 and Scribble/PAR. By using intestinal stem cell (ISC)-specific deletion of CDC42 in olfactomedin-4 (Olfm4)-internal ribosome entry site (IRES)-EGFP/CreERT2;CDC42

Indexed as

Adaptor Proteins, Signal TransducingAnimalscdc42 GTP-Binding ProteinCell DifferentiationCell LineageCell PolarityCell ProliferationEpidermal Growth FactorFemaleHippo Signaling PathwayIntestinesMaleMiceMice, Inbred C57BLSignal TransductionStem CellsAdaptor Proteins, Signal Transducingcdc42 GTP-Binding ProteinCdc42 protein, mouseEpidermal Growth FactorTOR Serine-Threonine KinasesCdc42cell fateHippo signalingintestinal stem cellsmouse modelmTOR signalingpolarity

Identifiers

PMID35021092
PMCPMC8826493
OpenAlexW4206568576

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.